Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Clin Perinatol. 2015 May 23;42(3):557–566. doi: 10.1016/j.clp.2015.04.016

Figure 2.

Figure 2

Changes in reticulocyte count (panel A) and hematocrit (panel B) in preterm infants treated with 4 weekly Darbe doses (0 ≥g/kg [placebo]: open squares; 2.5 ≥g/kg: solid triangles; 5≥g/kg: solid squares; 10 ≥g/kg: solid circles). Reticulocyte counts increased by day 14 in infants receiving either 5 or 10 ≥g/kg dosing. Infants receiving 10 ≥g/kg had the greatest reticulocyte response (p=0.04 versus placebo). Hematocrits were greater by day 14 in infants receiving any Darbe (p=0.006 versus placebo).